John J. Moore - Concepedia

Author

John J. Moore

Colorado School of Mines ORCID

Also Known As

J J Moore, J MOORE, J Moore, J. J. Moore, J. Moore, J.J Moore, J.J. MOORE, J.J. Moore, JOHN J. MOORE, JOHN MOORE

626

Publications

16.1K

Citations

H-Index

274

Concepts

All Affiliations

Colorado School of Mines Case Western Reserve University St Vincent's Hospital Sydney MetroHealth Medical Center Westmead Hospital

About

John J. Moore is an author at Colorado School of Mines specializing in engineering, materials science, and materials engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	45	128	6.8K
2	Medicine	30	69	3.5K
3	Health Sciences	8	8	384
4	Natural Sciences	4	4	90
5	Nursing	1	1	31

John J. Moore

257

Publications

13.5K

Citations

H-Index

Page 1

	Year	Citations
Combustion synthesis of advanced materials: Part I. Reaction parameters John J. Moore, H. J. Feng Progress in Materials Science Materials ScienceChemical EngineeringEngineeringReaction EngineeringCombustion Science	1995	822
Self-propagating high-temperature (combustion) synthesis (SHS) of powder-compacted materials H. C. Yi, John J. Moore Journal of Materials Science Materials EngineeringMaterials ScienceEngineeringCombustion SciencePowder-compacted Materials	1990	410
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases Dominique Farge, Myriam Labopin, Alan Tyndall, Haematologica	2009	355
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial Irwin Walker, Tony Panzarella, Stephen Couban, The Lancet Oncology Unrelated DonorsAnti-thymocyte GlobulinTransplantationMedicineHematology	2015	354
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4) Harry Iland, Ken Bradstock, Shane G. Supple, Blood	2012	336
A study of the oxidation behavior of CrN and CrAlN thin films in air using DSC and TGA analyses Jianliang Lin, Brajendra Mishra, John J. Moore, Surface and Coatings Technology Materials ScienceMaterials EngineeringChemical EngineeringTga AnalysesEngineering	2008	268
Combustion synthesis of advanced materials: Part II. Classification, applications and modelling John J. Moore, H. J. Feng Progress in Materials Science Materials ScienceChemical EngineeringEngineeringCombustion SynthesisCombustion Science	1995	243
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE) Basil Sharrack, Riccardo Saccardi, Tobias Alexander, Bone Marrow Transplantation Cell TherapyImmunologyImmunotherapyTranslational MedicineJoint Accreditation Committee	2019	239
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial C. Orla Morrissey, Sharon C.‐A. Chen, Tania C. Sorrell, The Lancet Infectious Diseases Invasive AspergillosisAntifungal AgentAntifungal AgentsClinical EpidemiologyPathology	2013	219
Autologous hematopoietic stem cell transplantation for autoimmune diseases Aloïs Gratwohl, Jakob Passweg, Chiara Bocelli‐Tyndall, Bone Marrow Transplantation Cell TherapyTransplantationAutoimmune DiseaseStem Cell TransplantationImmunology	2005	210

Page 1